PRAZOSIN PLASMA-CONCENTRATION AND BLOOD-PRESSURE REDUCTION

被引：29
作者：
LAROCHELLE, P
DUSOUICH, P
HAMET, P
LAROCQUE, P
ARMSTRONG, J
机构：
[1] HOTEL DIEU,INST CLIN RES,MONTREAL H2W 1T8,QUEBEC,CANADA
[2] UNIV MONTREAL,DEPT MED & PHARMACOL,MONTREAL H3C 3J7,QUEBEC,CANADA
来源：
HYPERTENSION | 1982年 / 4卷 / 01期
关键词：
D O I：
10.1161/01.HYP.4.1.93
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：93 / 101
页数：9
相关论文
共 16 条
[1]   PRAZOSIN, PHARMACOKINETICS AND CONCENTRATION EFFECT [J].
BATEMAN, DN ;
HOBBS, DC ;
TWOMEY, TM ;
STEVENS, EA ;
RAWLINS, MD .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :177-181
[2]   PRAZOSIN - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN HYPERTENSION [J].
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1977, 14 (03) :163-197
[3]  
CAMBRIDGE D, 1977, BRIT J PHARMACOL, V59, P514
[4]  
CAVERO T, 1977, CLIN EXP PHARM PH S3, V4, P61
[5]  
Constantine J. W., 1973, HYPERTENSION MECHANI, P429
[6]   SELECTIVITY OF BLOCKING-AGENTS FOR PRESYNAPTIC AND POSTSYNAPTIC ALPHA-ADRENOCEPTORS [J].
DOXEY, JC ;
SMITH, CFC ;
WALKER, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (01) :91-96
[7]  
GRAHAM RM, 1977, J PHARMACOL EXP THER, V201, P747
[8]  
GRAHAM RM, 1976, BRIT MED J, V2, P1283
[9]  
HESS HJ, 1974, PRAZOSIN EVALUATION, P3
[10]   CLINICAL PHARMACOKINETICS OF PRAZOSIN [J].
JAILLON, P .
CLINICAL PHARMACOKINETICS, 1980, 5 (04) :365-376
12